Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Talis Biomedical Corporation and Encourages Investors with Substantial Losses to Contact the Firm – Lawyer Monthly

RADNOR, Pa.-(BUSINESS WIRE)-$TLIS-The law firm of Kessler Topaz Meltzer & Check, LLP is informing investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation (“Talis”) (NASDAQ: TLIS). The lawsuit alleges Talis’ violations of federal securities laws, including omissions and fraudulent misrepresentations regarding the company’s business, operations and prospects. Talis investors have suffered significant losses as a result of Talis’ materially misleading public statements.

TO WATCH OUR VIDEO, PLEASE CLICK HERE

CLICK HERE TO SUBMIT YOUR TALIS LOSSES

DEADLINE FOR THE PLAINTIFF: March 8, 2022

COURSE PERIOD: February 12, 2021 to January 7, 2022

CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:

James Maro, Esq. (484) 270-1453 or toll free (844) 887-9500 or email info@ktmc.com

SUCH ALLEGED MISCONDUCT

Talis develops diagnostic tests to enable accurate, reliable, cost-effective and rapid molecular testing for infectious diseases. In particular, the Talis One tests are being developed for respiratory infections, infections related to women’s health and sexually transmitted infections. In its registration statement, Talis announced that in January 2021, the Company filed an Emergency Use Authorization (“EUA”) application with the United States Food and Drug Administration (“FDA”) for its Talis One platform to conduct COVID-19 submitted tests.

Then, on March 8, 2021, Talis announced that it had withdrawn its EUA application for the Talis One COVID-19 test. In a press release, Talis announced that “[i]In late February, the FDA informed the company that it cannot ensure that the comparator assay used in the primary study has sufficient sensitivity to support Talis’ EUA application.” Following the news, Talis’ stock price fell 1.80 $ or 12% to close on March 8, 2021 at $12.85 per share.

On August 10, 2021, Talis announced that its “development schedules have been extended due to delays in launches [Talis’] COVID-19 testing and production scale.” As a result of this news, Talis’ stock price fell $0.58 per share, or 6%, to close at $8.39 per share on August 11, 2021. Then, on August 30, 2021, Talis announced the resignation of its Chief Executive Officer (“CEO”). ), Brian Coe. As a result of this news, Talis’ stock price fell $1.00 per share, or 11%, to close at $8.06 per share on August 31, 2021. Finally, on December 8, 2021, Talis announced that Brian Blaser, who had been appointed CEO in November August 2021, had resigned from his position at Talis after just one week.

As a result of this news, Talis’ stock price fell $0.55 per share, or 11.39%, to close at $4.28 per share on December 8, 2021.

WHAT CAN I DO?

Talis investors can by March 8, 2022 at the latest, seek to be appointed lead plaintiff representative in the class action by Kessler Topaz Meltzer & Check, LLP or other counsel, or may elect to do nothing and remain an absentee class plaintiff. Kessler Topaz Meltzer & Check, LLP encourages Talis investors who have suffered material losses to contact the company directly for more information.

CLICK HERE TO REGISTER FOR THE EVENT

Who can be a lead plaintiff?

A Lead Plaintiff is a representative party acting on behalf of all Group Members in conducting the litigation. The lead plaintiff is usually the investor or small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and class, and such attorneys, where permitted by the court, are principal or class counsel. Your ability to participate in a recovery will not be affected by the decision whether or not to serve as Lead Plaintiff.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP

Kessler Topaz Meltzer & Check, LLP is pursuing class action lawsuits in state and federal courts across the country and around the world. The company has built an excellent reputation around the world, recovering billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, wrongdoing and negligence on the part of companies and fiduciaries. At the end of the day, if the bad guys pay and you get your fortune back, we’re done. The action in this lawsuit was not filed by Kessler Topaz Meltzer & Check, LLP. Additional information about Kessler Topaz Meltzer & Check, LLP is available at www.ktmc.com.

contacts

Kessler Topaz Meltzer & Check, LLP

James Maro, Jr., Esq.

280 König-von-Prussia-Strasse

Radnor, PA 19087

(844) 887-9500 (toll free)

info@ktmc.com

Comments are closed.